• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于下一代测序数据的微卫星不稳定性评估。

Assessment of Microsatellite Instability from Next-Generation Sequencing Data.

机构信息

Laboratory for Bioinformatics, Foundation Jean Dausset - CEPH, Paris, France.

Laboratory for Genomics, Foundation Jean Dausset - CEPH, Paris, France.

出版信息

Adv Exp Med Biol. 2022;1361:75-100. doi: 10.1007/978-3-030-91836-1_5.

DOI:10.1007/978-3-030-91836-1_5
PMID:35230684
Abstract

Microsatellite instability (MSI) is a genetic alteration due to a deficiency of the DNA mismatch repair system, where microsatellites accumulate insertions/deletions. This phenotype has been extensively characterized in colorectal cancer and is also sought in the context of Lynch syndrome diagnosis. It has recently been described in dozens of cancer types from whole genome/exome sequencing data, bearing some prognostic information. Moreover, MSI has also proven to be a major predicator of the response to immune checkpoint blockade therapy in solid cancer patients. Among the different methods developed for MSI detection in cancer, next-generation sequencing (NGS) is a promising and versatile technology offering many possibilities and advantages in diverse clinical applications compared to the gold standard PCR and capillary electrophoresis approach. NGS could notably increase the number of analyzed microsatellites and potentially be used to analyze other genetic alterations required for precision oncology. However, it requires the development of robust new computational algorithms for the analysis of NGS microsatellite data. In this chapter, we describe the different approaches developed for the assessment of MSI from NGS data in cancer, including the different microsatellite panels and computational algorithms proposed, highlighting their advantages and drawbacks, and their evaluation in different clinical applications.

摘要

微卫星不稳定性(MSI)是由于 DNA 错配修复系统缺陷导致的遗传改变,微卫星在此过程中积累插入/缺失。这种表型在结直肠癌中得到了广泛的描述,并且也在林奇综合征诊断的背景下进行了研究。最近,通过全基因组/外显子测序数据,在几十种癌症类型中也描述了这种表型,并且具有一定的预后信息。此外,MSI 也被证明是实体瘤患者对免疫检查点阻断治疗反应的主要预测因子。在用于癌症 MSI 检测的不同方法中,下一代测序(NGS)是一种很有前途和多功能的技术,与金标准 PCR 和毛细管电泳方法相比,在各种临床应用中提供了许多可能性和优势。NGS 可以显著增加分析的微卫星数量,并有可能用于分析其他需要精准肿瘤学的遗传改变。然而,它需要开发强大的新计算算法来分析 NGS 微卫星数据。在本章中,我们描述了从癌症 NGS 数据中评估 MSI 的不同方法,包括提出的不同微卫星面板和计算算法,强调了它们的优点和缺点,以及它们在不同临床应用中的评估。

相似文献

1
Assessment of Microsatellite Instability from Next-Generation Sequencing Data.基于下一代测序数据的微卫星不稳定性评估。
Adv Exp Med Biol. 2022;1361:75-100. doi: 10.1007/978-3-030-91836-1_5.
2
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.使用结直肠癌患者的外显子组测序数据对微卫星状态的计算测定进行验证。
BMC Cancer. 2019 Oct 21;19(1):971. doi: 10.1186/s12885-019-6227-7.
3
Quantitative evaluation of MSI testing using NGS detects the imperceptible microsatellite changed caused by MSH6 deficiency.使用 NGS 对 MSI 检测进行定量评估可检测到由 MSH6 缺陷引起的难以察觉的微卫星改变。
Fam Cancer. 2021 Apr;20(2):137-143. doi: 10.1007/s10689-020-00203-3.
4
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers.微卫星不稳定性:从检测的实施到癌症的预后和预测作用。
Int J Mol Sci. 2022 Aug 5;23(15):8726. doi: 10.3390/ijms23158726.
5
An Innovative and Accurate Next-Generation Sequencing-Based Microsatellite Instability Detection Method for Colorectal and Endometrial Tumors.一种基于新一代测序的创新且准确的用于检测结直肠癌和子宫内膜癌微卫星不稳定性的方法。
Lab Invest. 2024 Feb;104(2):100297. doi: 10.1016/j.labinv.2023.100297. Epub 2023 Nov 25.
6
A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.一种通过下一代测序检测结直肠癌微卫星不稳定性的新颖可靠方法。
J Mol Diagn. 2018 Mar;20(2):225-231. doi: 10.1016/j.jmoldx.2017.11.007. Epub 2017 Dec 19.
7
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.ESMO 关于免疫治疗中肿瘤微卫星不稳定性检测的建议,及其与 PD-1/PD-L1 表达和肿瘤突变负担的关系:基于系统评价的方法。
Ann Oncol. 2019 Aug 1;30(8):1232-1243. doi: 10.1093/annonc/mdz116.
8
Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer.用于检测癌症中微卫星不稳定性的分子和计算方法
Front Oncol. 2018 Dec 12;8:621. doi: 10.3389/fonc.2018.00621. eCollection 2018.
9
Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing.通过下一代测序检测微卫星不稳定性生物标志物
Methods Mol Biol. 2020;2055:119-132. doi: 10.1007/978-1-4939-9773-2_5.
10
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.一种基于下一代测序的策略,结合微卫星不稳定性和肿瘤突变负担,用于晚期结直肠癌的综合分子诊断。
BMC Cancer. 2021 Mar 16;21(1):282. doi: 10.1186/s12885-021-07942-1.

引用本文的文献

1
Elucidating the Role of , , and Mutations and Microsatellite Instability in Colorectal Cancer via Next-Generation Sequencing.通过下一代测序阐明、、和突变以及微卫星不稳定性在结直肠癌中的作用。
Cancers (Basel). 2025 Jun 20;17(13):2071. doi: 10.3390/cancers17132071.
2
MSI expresso: a software for determining MSI status and detecting MSI-related transcription events from RNA sequencing data.MSI expresso:一款用于从RNA测序数据中确定微卫星不稳定性(MSI)状态并检测与MSI相关转录事件的软件。
Front Genet. 2025 Apr 24;16:1523278. doi: 10.3389/fgene.2025.1523278. eCollection 2025.
3
A detailed analysis of second and third-generation sequencing approaches for accurate length determination of short tandem repeats and homopolymers.

本文引用的文献

1
Microsatellite instability status is determined by targeted sequencing with MSIcall in 25 cancer types.微卫星不稳定性状态通过 MSIcall 在 25 种癌症类型中进行靶向测序来确定。
Clin Chim Acta. 2020 Mar;502:207-213. doi: 10.1016/j.cca.2019.11.002. Epub 2019 Nov 13.
2
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.使用结直肠癌患者的外显子组测序数据对微卫星状态的计算测定进行验证。
BMC Cancer. 2019 Oct 21;19(1):971. doi: 10.1186/s12885-019-6227-7.
3
Standardization of Sequencing Coverage Depth in NGS: Recommendation for Detection of Clonal and Subclonal Mutations in Cancer Diagnostics.
用于精确测定短串联重复序列和同聚物长度的第二代和第三代测序方法的详细分析。
Nucleic Acids Res. 2025 Feb 27;53(5). doi: 10.1093/nar/gkaf131.
4
Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing.子宫内膜癌中错配修复缺陷的检测:基于免疫组化、片段长度分析和扩增子测序的微卫星不稳定性检测评估
Cancers (Basel). 2024 Nov 26;16(23):3970. doi: 10.3390/cancers16233970.
5
[Endometrial carcinoma: molecular classification in routine pathology].[子宫内膜癌:常规病理学中的分子分类]
Pathologie (Heidelb). 2024 Sep;45(5):347-354. doi: 10.1007/s00292-024-01345-2. Epub 2024 Aug 14.
6
Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency between PCR and IHC.结直肠癌的微卫星状态检测:聚合酶链反应与免疫组化之间不一致性的评估
J Cancer. 2023 Apr 17;14(7):1132-1140. doi: 10.7150/jca.81675. eCollection 2023.
7
An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing.一种使用全外显子组DNA和RNA工作流程进行癌症生物标志物检测的绝对方法。
Front Oncol. 2023 Mar 13;13:1002792. doi: 10.3389/fonc.2023.1002792. eCollection 2023.
二代测序中测序覆盖深度的标准化:癌症诊断中克隆性和亚克隆性突变检测的建议
Front Oncol. 2019 Sep 4;9:851. doi: 10.3389/fonc.2019.00851. eCollection 2019.
4
An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine.新一代测序和精准医学时代下微卫星不稳定性的最新综述。
Semin Oncol. 2019 Jun;46(3):261-270. doi: 10.1053/j.seminoncol.2019.08.003. Epub 2019 Sep 11.
5
Ushering in Liquid Biopsy for the Microsatellite Status: Advantages and Caveats.开启微卫星状态的液体活检时代:优势与注意事项。
Clin Cancer Res. 2019 Dec 1;25(23):6887-6889. doi: 10.1158/1078-0432.CCR-19-2585. Epub 2019 Sep 16.
6
Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade.程序性死亡受体 1(PD-1)阻断治疗的癌症患者中微卫星不稳定性和高肿瘤突变负荷的无创检测
Clin Cancer Res. 2019 Dec 1;25(23):7024-7034. doi: 10.1158/1078-0432.CCR-19-1372. Epub 2019 Sep 10.
7
Sequencing-based microsatellite instability testing using as few as six markers for high-throughput clinical diagnostics.采用基于测序的微卫星不稳定性检测,使用少至六个标志物进行高通量临床诊断。
Hum Mutat. 2020 Jan;41(1):332-341. doi: 10.1002/humu.23906. Epub 2019 Sep 15.
8
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.错配修复缺陷肿瘤的遗传多样性影响抗 PD-1 免疫治疗反应。
Science. 2019 May 3;364(6439):485-491. doi: 10.1126/science.aau0447.
9
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.美国食品药品监督管理局批准摘要:帕博利珠单抗用于治疗微卫星高度不稳定实体瘤。
Clin Cancer Res. 2019 Jul 1;25(13):3753-3758. doi: 10.1158/1078-0432.CCR-18-4070. Epub 2019 Feb 20.
10
A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes.一种通过外周血白细胞测序来诊断遗传性错配修复缺陷的敏感且可扩展的微卫星不稳定性检测方法。
Hum Mutat. 2019 May;40(5):649-655. doi: 10.1002/humu.23721. Epub 2019 Mar 6.